Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

In utero nucleoside reverse transcriptase inhibitor exposure and cancer in HIV-uninfected children: an update from the pediatric AIDS clinical trials group 219 and 219C cohorts.

Brogly S, Williams P, Seage GR 3rd, Van Dyke R.

J Acquir Immune Defic Syndr. 2006 Apr 1;41(4):535-6. No abstract available.

PMID:
16652068
2.

In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.

Brogly SB, Ylitalo N, Mofenson LM, Oleske J, Van Dyke R, Crain MJ, Abzug MJ, Brady M, Jean-Philippe P, Hughes MD, Seage GR 3rd.

AIDS. 2007 May 11;21(8):929-38.

PMID:
17457086
3.

Incidence of cancer in children perinatally exposed to nucleoside reverse transcriptase inhibitors.

Benhammou V, Warszawski J, Bellec S, Doz F, André N, Lacour B, Levine M, Bavoux F, Tubiana R, Mandelbrot L, Clavel J, Blanche S; ANRS-Enquête Périnatale Française.

AIDS. 2008 Oct 18;22(16):2165-77. doi: 10.1097/QAD.0b013e328311d18b. Erratum in: AIDS. 2012 May 15;26(8):1047. Carbillon, François F [corrected to Carbillon, L].

PMID:
18832880
4.

[Non-nucleoside reverse transcriptase inhibitor as a fully viable alternative. Strong therapy start without protease inhibitor].

[No authors listed]

MMW Fortschr Med. 2000 Mar 13;142 Suppl 1:30-3. German. No abstract available.

PMID:
10863307
6.

Special issue on health risks of perinatal exposure to nucleoside reverse transcriptase inhibitors.

Walker VE, Poirier MC.

Environ Mol Mutagen. 2007 Apr-May;48(3-4):159-65. No abstract available.

PMID:
17358025
7.

Altered heterochromatin organization after perinatal exposure to zidovudine.

Senda S, Blanche S, Costagliola D, Cibert C, Nigon F, Firtion G, Floch C, Parat S, Viegas-Péquignot E.

Antivir Ther. 2007;12(2):179-87. Erratum in: Antivir Ther. 2007;12(3):429.

PMID:
17503660
8.

[Nevirapine--the first non-nucleoside inhibitor of reverse transcriptase in the battle against AIDS].

Wiese E.

Pharm Unserer Zeit. 1997 Mar;26(2):99-100. German. No abstract available.

PMID:
9289739
9.

[Non-nucleoside reverse transcriptase inhibitors. AIDS long-term management].

Sautter R.

Fortschr Med. 1998 Jul 20;116(20-21):56-7. German. No abstract available.

PMID:
9738345
10.

Reversible zidovudine-induced pure red cell aplasia.

Blanche P, Silberman B, Barreto L, Gombert B, Sicard D.

AIDS. 1999 Aug 20;13(12):1586-7. No abstract available.

PMID:
10465087
11.

HIV and mitochondrial toxicity in children.

Foster C, Lyall H.

J Antimicrob Chemother. 2008 Jan;61(1):8-12. Epub 2007 Nov 13. Review.

PMID:
17999978
12.

Novel treatment options for pediatric HIV infection.

Day E, Buckberry K, Sharland MR, Chakraborty R.

Curr Opin Investig Drugs. 2008 Feb;9(2):170-5. Review.

PMID:
18246519
13.

Follow-up of children exposed to perinatal antiretrovirals.

Fowler MG.

Teratology. 2000 May;61(5):395-6. Review. No abstract available.

PMID:
10777838
14.

[Antiretroviral therapy of acquired immunodeficiency syndrome (AIDS)].

Jevtović Dj, Ranin J, Salemović D, Brmbolić B, Zerjav S.

Srp Arh Celok Lek. 1992 Nov;120 Suppl 5:38-41. Review. Serbian.

PMID:
18170976
15.

Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States.

Persaud D, Palumbo P, Ziemniak C, Chen J, Ray SC, Hughes M, Havens P, Purswani M, Gaur AH, Chadwick EG; Pediatric AIDS Clinical Trials Group P1030 Team.

J Infect Dis. 2007 May 15;195(10):1402-10. Epub 2007 Apr 5.

PMID:
17436219
16.

[Antiretroviral therapy of HIV infections. New recommendations by the International AIDS Society].

Allouch H.

Presse Med. 1998 Nov 7;27(34):1739-41. French. No abstract available.

PMID:
9835934
17.

Does perinatal antiretroviral therapy create an iatrogenic cancer risk?

Wogan GN.

Environ Mol Mutagen. 2007 Apr-May;48(3-4):210-4.

PMID:
17358028
18.

Severe anaphylactic shock after rechallenge with abacavir without preceding hypersensitivity.

Frissen PH, de Vries J, Weigel HM, Brinkman K.

AIDS. 2001 Jan 26;15(2):289. No abstract available.

PMID:
11216946
19.

Long-term effectiveness of highly active antiretroviral therapy (HAART) in perinatally HIV-infected children in Denmark.

Bracher L, Valerius NH, Rosenfeldt V, Herlin T, Fisker N, Nielsen H, Obel N.

Scand J Infect Dis. 2007;39(9):799-804.

PMID:
17701719
20.

Current clinical treatments of AIDS.

Murphy EM, Jimenez HR, Smith SM.

Adv Pharmacol. 2008;56:27-73. Review. No abstract available.

PMID:
18086408

Supplemental Content

Support Center